Dr Juswinder Singh is a world-renowned computational chemist and drug designer, who received his PhD in Computer-based Drug Design at Birkbeck. He is the Founder and Chief Scientific Officer of Ankaa Therapeutics, pioneering the development of targeted therapies to address drug resistance. In 2016, Dr Singh was given the George & Christine Sosnovsky Award for Cancer Research by the American Cancer Society, for leading the development of targeted covalent drugs that are having a transformative impact on the treatment of cancer patients.

A transcript of this podcast is also available to read